Hana Biosciences, Inc. Announces $14.7 Million Private Placement

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 19, 2005--Hana Biosciences Inc. (AMEX: HBX), a South San Francisco-based biopharmaceutical company focused on advancing cancer care, announced today that it has received commitments led by several institutional investors to purchase approximately 3.7 million shares of Hana's common stock at a price of $4.00 per share, resulting in aggregate gross proceeds of approximately $14.7 million. The investors will also receive warrants to purchase an additional 737,000 common shares. The transaction is subject to certain customary closing conditions and is expected to close by Oct. 21, 2005.